Dr. Eric T. Rush, M.D.
Medical Genetics (Clinical Genetics (M.D.) Physician)
- Medicare participating
At a glance
- Medical school
- University of Kansas School of Med (Kc/Wich/Sal) (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 11
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Kansas School of Med (Kc/Wich/Sal)
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Genetics (M.D.) Physician primary
MO license 2017013707 · NE license 24664
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- The Childrens Mercy Hospital (135 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 11
- Services billed
- 13
- Patients’ average age
- 60
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Strensiq (asfotase alfa) | 83 |
| Vimizim (elosulfase alfa) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 147 payments worth $151,613 in total to this clinician.
| Alexion Pharmaceuticals, Inc. | $114,229 |
|---|---|
| Kyowa Kirin, Inc. | $37,384 |
| Compensation for services other than consulting (speaking, faculty) | $96,443 |
|---|---|
| Travel and Lodging | $26,907 |
| Consulting Fee | $26,693 |
| Food and Beverage | $1,571 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. Jul 1, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $19,680 |
| Alexion Pharmaceuticals, Inc. May 27, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Tokyo, Japan · in-kind Company’s descriptionSpeaker Expenses | $10,245 |
| Kyowa Kirin, Inc. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,500 |
| Kyowa Kirin, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,500 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Consulting Fee | $5,330 |
| Kyowa Kirin, Inc. Aug 25, 2025 | Compensation for services other than consulting (speaking, faculty) CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $4,950 |
| Kyowa Kirin, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,950 |
| Alexion Pharmaceuticals, Inc. Nov 6, 2025 | Consulting Fee STRENSIQ · Rare Disease | $4,920 |
| Alexion Pharmaceuticals, Inc. Nov 6, 2025 | Consulting Fee STRENSIQ · Rare Disease | $4,920 |
| Kyowa Kirin, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $4,125 |
All 111 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. Dec 15, 2025 | Consulting Fee STRENSIQ · Rare Disease | $1,538 |
| Kyowa Kirin, Inc. Dec 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,375 |
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Consulting Fee STRENSIQ · Rare Disease | $2,050 |
| Alexion Pharmaceuticals, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Nov 20, 2025 | Consulting Fee STRENSIQ · Rare Disease | $820 |
| Kyowa Kirin, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) | $688 |
| Kyowa Kirin, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,375 |
| Alexion Pharmaceuticals, Inc. Nov 17, 2025 | Consulting Fee | $3,690 |
| Alexion Pharmaceuticals, Inc. Nov 13, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Denver, CO · in-kind Company’s descriptionSpeaker Expenses | $428 |
| Alexion Pharmaceuticals, Inc. Nov 13, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Kansas City, MO | $28.91 |
| Alexion Pharmaceuticals, Inc. Nov 6, 2025 | Consulting Fee STRENSIQ · Rare Disease | $4,920 |
| Alexion Pharmaceuticals, Inc. Nov 6, 2025 | Consulting Fee STRENSIQ · Rare Disease | $4,920 |
| Kyowa Kirin, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,950 |
| Alexion Pharmaceuticals, Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,230 |
| Kyowa Kirin, Inc. Oct 11, 2025 | Travel and Lodging travel to ALBANY, NY · in-kind | $677 |
| Kyowa Kirin, Inc. Oct 11, 2025 | Travel and Lodging travel to ALBANY, NY | $285 |
| Kyowa Kirin, Inc. Oct 11, 2025 | Travel and Lodging travel to KANSAS CITY, MO | $34.72 |
| Kyowa Kirin, Inc. Oct 11, 2025 | Travel and Lodging travel to ALBANY, NY | $28.70 |
| Kyowa Kirin, Inc. Oct 11, 2025 | Travel and Lodging travel to ALBANY, NY | $16.82 |
| Kyowa Kirin, Inc. Oct 10, 2025 | Travel and Lodging travel to ALBANY, NY | $24.00 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Sep 8, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Denver, CO · in-kind Company’s descriptionSpeaker Expenses | $332 |
| Alexion Pharmaceuticals, Inc. Sep 7, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Seattle, WA | $81.06 |
| Alexion Pharmaceuticals, Inc. Sep 7, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Kansas City, MO | $70.00 |
| Alexion Pharmaceuticals, Inc. Sep 7, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Seattle, WA | $35.00 |
| Alexion Pharmaceuticals, Inc. Sep 6, 2025 | Travel and Lodging travel to Seattle, WA · in-kind Company’s descriptionSpeaker Expenses | $682 |
| Alexion Pharmaceuticals, Inc. Sep 6, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Seattle, WA | $366 |
| Alexion Pharmaceuticals, Inc. Sep 3, 2025 | Travel and Lodging travel to Seattle, WA | $366 |
| Alexion Pharmaceuticals, Inc. Sep 3, 2025 | Travel and Lodging travel to Bothell, WA | $72.77 |
| Alexion Pharmaceuticals, Inc. Sep 3, 2025 | Travel and Lodging travel to Seattle, WA | $35.00 |
| Alexion Pharmaceuticals, Inc. Aug 27, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,230 |
| Kyowa Kirin, Inc. Aug 25, 2025 | Compensation for services other than consulting (speaking, faculty) CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $4,950 |
| Kyowa Kirin, Inc. Aug 9, 2025 | Travel and Lodging CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY · travel to KANSAS CITY, MO | $84.00 |
| Kyowa Kirin, Inc. Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $413 |
| Kyowa Kirin, Inc. Jul 24, 2025 | Consulting Fee | $275 |
| Alexion Pharmaceuticals, Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $2,460 |
| Alexion Pharmaceuticals, Inc. Jul 1, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $19,680 |
| Alexion Pharmaceuticals, Inc. Jul 1, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Tokyo, Japan | $224 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Aurora, CO · in-kind Company’s descriptionSpeaker Expenses | $854 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Aurora, CO · in-kind Company’s descriptionSpeaker Expenses | $233 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Kansas City, MO | $42.00 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Aurora, CO | $15.26 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging travel to Boston, MA | $500 |
| Kyowa Kirin, Inc. Jun 18, 2025 | Travel and Lodging CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY · travel to CHICAGO, IL | $37.98 |
| Kyowa Kirin, Inc. Jun 18, 2025 | Travel and Lodging CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY · travel to CHICAGO, IL | $28.00 |
| Kyowa Kirin, Inc. Jun 18, 2025 | Travel and Lodging CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY · travel to CHICAGO, IL | $22.50 |
| Alexion Pharmaceuticals, Inc. Jun 2, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Tokyo, Japan · in-kind Company’s descriptionSpeaker Expenses | $157 |
| Alexion Pharmaceuticals, Inc. May 29, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,230 |
| Alexion Pharmaceuticals, Inc. May 28, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Tokyo, Japan · in-kind Company’s descriptionSpeaker Expenses | $2,990 |
| Alexion Pharmaceuticals, Inc. May 27, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Tokyo, Japan · in-kind Company’s descriptionSpeaker Expenses | $10,245 |
| Alexion Pharmaceuticals, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,230 |
| Alexion Pharmaceuticals, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $1,230 |
| Alexion Pharmaceuticals, Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $1,230 |
| Kyowa Kirin, Inc. May 15, 2025 | Consulting Fee CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $1,100 |
| Alexion Pharmaceuticals, Inc. May 15, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Springfield, MO | $249 |
| Kyowa Kirin, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $4,125 |
| Kyowa Kirin, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | $3,300 |
| Alexion Pharmaceuticals, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $1,230 |
| Kyowa Kirin, Inc. Apr 26, 2025 | Travel and Lodging CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY · travel to CHICAGO, IL · in-kind | $361 |
| Kyowa Kirin, Inc. Apr 26, 2025 | Travel and Lodging CRYSVITA · FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY · travel to CHICAGO, IL · in-kind | $187 |
| Alexion Pharmaceuticals, Inc. Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Apr 5, 2025 | Travel and Lodging travel to Pittsburgh, PA · in-kind Company’s descriptionSpeaker Expenses | $268 |
| Alexion Pharmaceuticals, Inc. Apr 5, 2025 | Travel and Lodging travel to Pittsburgh, PA · in-kind Company’s descriptionSpeaker Expenses | $233 |
| Alexion Pharmaceuticals, Inc. Apr 5, 2025 | Travel and Lodging travel to Pittsburgh, PA | $68.59 |
| Alexion Pharmaceuticals, Inc. Apr 5, 2025 | Travel and Lodging travel to Pittsburgh, PA | $60.65 |
| Alexion Pharmaceuticals, Inc. Apr 5, 2025 | Travel and Lodging travel to Kansas City, MO | $28.00 |
| Kyowa Kirin, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,500 |
| Alexion Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging travel to Augusta, GA | $126 |
| Alexion Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging travel to Kansas City, KS | $80.00 |
| Alexion Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging travel to Augusta, GA | $23.96 |
| Alexion Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to Augusta, GA · in-kind Company’s descriptionSpeaker Expenses | $467 |
| Alexion Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to Arlington, VA · in-kind Company’s descriptionSpeaker Expenses | $398 |
| Alexion Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind Company’s descriptionSpeaker Expenses | $249 |
| Alexion Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to Atlanta, GA | $25.00 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Consulting Fee | $5,330 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Travel and Lodging travel to Bethesda, MD · in-kind Company’s descriptionSpeaker Expenses | $192 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Travel and Lodging travel to Washington, DC | $62.08 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Travel and Lodging travel to Arlington, VA | $43.23 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Travel and Lodging travel to Arlington, VA | $35.00 |
| Kyowa Kirin, Inc. Mar 13, 2025 | Travel and Lodging travel to NEW YORK, NY | $111 |
| Kyowa Kirin, Inc. Mar 13, 2025 | Travel and Lodging travel to ELMHURST, NY | $86.59 |
| Kyowa Kirin, Inc. Mar 13, 2025 | Travel and Lodging travel to KANSAS CITY, MO | $28.00 |
| Kyowa Kirin, Inc. Mar 13, 2025 | Travel and Lodging travel to NEW YORK, NY | $16.69 |
| Kyowa Kirin, Inc. Mar 12, 2025 | Travel and Lodging travel to NEW YORK, NY · in-kind | $403 |
| Kyowa Kirin, Inc. Mar 12, 2025 | Travel and Lodging travel to NEW YORK, NY · in-kind | $266 |
| Kyowa Kirin, Inc. Mar 12, 2025 | Travel and Lodging travel to NEW YORK, NY | $42.47 |
| Alexion Pharmaceuticals, Inc. Mar 6, 2025 | Travel and Lodging travel to Kansas City, MO Company’s descriptionConsulting Expenses | $84.00 |
| Alexion Pharmaceuticals, Inc. Mar 5, 2025 | Travel and Lodging travel to Las Vegas, NV · in-kind Company’s descriptionConsulting Expenses | $311 |
| Alexion Pharmaceuticals, Inc. Mar 5, 2025 | Travel and Lodging travel to Las Vegas, NV · in-kind Company’s descriptionConsulting Expenses | $169 |
| Alexion Pharmaceuticals, Inc. Mar 5, 2025 | Travel and Lodging travel to Las Vegas, NV · in-kind Company’s descriptionConsulting Expenses | $79.37 |
| Alexion Pharmaceuticals, Inc. Mar 4, 2025 | Travel and Lodging travel to Las Vegas, NV · in-kind Company’s descriptionConsulting Expenses | $1,035 |
| Alexion Pharmaceuticals, Inc. Mar 4, 2025 | Travel and Lodging travel to Las Vegas, NV Company’s descriptionConsulting Expenses | $518 |
| Kyowa Kirin, Inc. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,500 |
| Alexion Pharmaceuticals, Inc. Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $718 |
| Alexion Pharmaceuticals, Inc. Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,280 |
| Alexion Pharmaceuticals, Inc. Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) STRENSIQ · Rare Disease Company’s descriptionSpeaker Fee | $3,280 |
| Kyowa Kirin, Inc. Feb 13, 2025 | Travel and Lodging travel to ST. LOUIS, MO | $330 |
| Kyowa Kirin, Inc. Feb 13, 2025 | Travel and Lodging travel to COLUMBIA, MO · in-kind | $229 |
| Alexion Pharmaceuticals, Inc. Feb 7, 2025 | Travel and Lodging travel to Omaha, NE | $249 |
| Alexion Pharmaceuticals, Inc. Feb 5, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Las Vegas, NV · in-kind Company’s descriptionSpeaker Expenses | $418 |
| Alexion Pharmaceuticals, Inc. Feb 5, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Las Vegas, NV · in-kind Company’s descriptionSpeaker Expenses | $259 |
| Alexion Pharmaceuticals, Inc. Feb 5, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Las Vegas, NV | $37.97 |
| Alexion Pharmaceuticals, Inc. Feb 5, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Las Vegas, NV | $33.44 |
| Alexion Pharmaceuticals, Inc. Feb 5, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Kansas City, KS | $32.00 |
| Alexion Pharmaceuticals, Inc. Feb 5, 2025 | Travel and Lodging STRENSIQ · Rare Disease · travel to Las Vegas, NV | $15.88 |
| Alexion Pharmaceuticals, Inc. Jan 8, 2025 | Consulting Fee STRENSIQ · Rare Disease | $2,050 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 2 companies. The companies reported $378,031 in research payments for these studies, mostly to the institutions running them.
- Study name not reported
Ultragenyx Pharmaceutical Inc. - A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safety and Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric Participants (2 to less t…
Alexion Pharmaceuticals, Inc. - A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN1850 Versus Placebo Administered Subcutaneously in Pediatric (2 to 12 years of age) Participants with…
Alexion Pharmaceuticals, Inc. - Study name not reported
Ultragenyx Pharmaceutical Inc. - An Observational, Longitudinal, Prospective, Long term Registry of Patients with Hypophosphatasia
Alexion Pharmaceuticals, Inc. - A Prospective Observational Sub Study of the Global Hypophosphatasia Registry to Evaluate the Potential Risk of Immune Mediated Loss of Pharmacological Effect of Asfotase Alfa in Participants with Hypophosphatasia.
Alexion Pharmaceuticals, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.